These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2633927)

  • 1. Pharmacokinetics/bioavailability of colchicine in healthy male volunteers.
    Achtert G; Scherrmann JM; Christen MO
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):317-22. PubMed ID: 2633927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses.
    Ferron GM; Rochdi M; Jusko WJ; Scherrmann JM
    J Clin Pharmacol; 1996 Oct; 36(10):874-83. PubMed ID: 8930773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute bioavailability of moxonidine.
    Theodor R; Weimann HJ; Weber W; Michaelis K
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):153-9. PubMed ID: 1936074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zero-order absorption and linear disposition of oral colchicine in healthy volunteers.
    Thomas G; Girre C; Scherrmann JM; Francheteau P; Steimer JL
    Eur J Clin Pharmacol; 1989; 37(1):79-84. PubMed ID: 2591469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
    Rochdi M; Sabouraud A; Girre C; Venet R; Scherrmann JM
    Eur J Clin Pharmacol; 1994; 46(4):351-4. PubMed ID: 7957521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-independent pharmacokinetics of colchicine after oral administration to healthy volunteers.
    Girre C; Thomas G; Scherrmann JM; Crouzette J; Fournier PE
    Fundam Clin Pharmacol; 1989; 3(5):537-43. PubMed ID: 2606428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
    Weinling E; Sandouk P; Debray M; Scherrmann JM
    Int J Clin Pharmacol Ther; 1999 Oct; 37(10):503-9. PubMed ID: 10543318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of thiocolchicoside in humans using a specific radioimmunoassay.
    Sandouk P; Chappey O; d'Yvoire MB; Scherrmann JM
    Ther Drug Monit; 1995 Oct; 17(5):544-8. PubMed ID: 8585121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases.
    Rochdi M; Sabouraud A; Baud FJ; Bismuth C; Scherrmann JM
    Hum Exp Toxicol; 1992 Nov; 11(6):510-6. PubMed ID: 1361141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers.
    Sandouk P; Bouvier d'Yvoire M; Chretien P; Tillement JP; Scherrmann JM
    Biopharm Drug Dispos; 1994 Jan; 15(1):87-92. PubMed ID: 8161719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dose proportionality of domperidone in healthy volunteers.
    Huang YC; Colaizzi JL; Bierman RH; Woestenborghs R; Heykants JJ
    J Clin Pharmacol; 1986; 26(8):628-32. PubMed ID: 3793955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine disposition in patients with familial Mediterranean fever with renal impairment.
    Ben-Chetrit E; Scherrmann JM; Zylber-Katz E; Levy M
    J Rheumatol; 1994 Apr; 21(4):710-3. PubMed ID: 8035398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment.
    Rudi J; Raedsch R; Gerteis C; Schlenker T; Plachky J; Walter-Sack I; Sabouraud A; Scherrmann JM; Kommerell B
    Scand J Gastroenterol; 1994 Apr; 29(4):346-51. PubMed ID: 8047810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are dosing adjustments required for colchicine in the elderly compared with younger patients?
    Wason S; Faulkner RD; Davis MW
    Adv Ther; 2012 Jun; 29(6):551-61. PubMed ID: 22753019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of a newly developed 5-mg levomethadone hydrochloride IR tablet (L-Polamidon® 5 mg tablets) in comparison with the 5-mg levomethadone hydrochloride oral solution (L-Polamidon® solution for substitution) as reference product.
    Blume HH; Wedemeyer RS; Donath F; Roscher K; Elvert G; Wagner D; Bley O; Vuia A; Todorova-Sanjari M; Villalobos R; Schug B
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):335-44. PubMed ID: 25669614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.